Shandong Financial Statements From 2010 to 2026
| SHWGF Stock | USD 0.69 0.00 0.00% |
Check Shandong Weigao financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Shandong Weigao's main balance sheet or income statement drivers, such as , as well as many indicators such as . Shandong financial statements analysis is a perfect complement when working with Shandong Weigao Valuation or Volatility modules.
Shandong |
Shandong Weigao Group Company Return On Equity Analysis
Shandong Weigao's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Shandong Weigao Return On Equity | 0.13 |
Most of Shandong Weigao's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shandong Weigao Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Shandong Weigao Group has a Return On Equity of 0.1276. This is 100.53% lower than that of the Healthcare sector and 102.13% lower than that of the Medical Instruments & Supplies industry. The return on equity for all United States stocks is 141.16% lower than that of the firm.
Shandong Weigao Group Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Shandong Weigao's current stock value. Our valuation model uses many indicators to compare Shandong Weigao value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Shandong Weigao competition to find correlations between indicators driving Shandong Weigao's intrinsic value. More Info.Shandong Weigao Group is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers reporting about 0.47 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Shandong Weigao Group is roughly 2.11 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Shandong Weigao's earnings, one of the primary drivers of an investment's value.About Shandong Weigao Financial Statements
Shandong Weigao stakeholders use historical fundamental indicators, such as Shandong Weigao's revenue or net income, to determine how well the company is positioned to perform in the future. Although Shandong Weigao investors may analyze each financial statement separately, they are all interrelated. For example, changes in Shandong Weigao's assets and liabilities are reflected in the revenues and expenses on Shandong Weigao's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Shandong Weigao Group. Please read more on our technical analysis and fundamental analysis pages.
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the Peoples Republic of China. The company was incorporated in 2000 and is based in Weihai, the Peoples Republic of China. Shandong Weigao operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. It employs 11476 people.
Currently Active Assets on Macroaxis
Other Information on Investing in Shandong Pink Sheet
Shandong Weigao financial ratios help investors to determine whether Shandong Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shandong with respect to the benefits of owning Shandong Weigao security.